Literature DB >> 25698379

Practical opportunities to improve early detection and prevention of colorectal cancer (CRC) in members of high-risk families.

S G Patel1, J T Lowery, D Gatof, D J Ahnen.   

Abstract

Colorectal cancer (CRC) incidence and mortality are steadily declining and CRC screening rates are increasing in the United States. Although this a very good news, several definable groups still have very low screening rates including younger (under age 50) members of high-risk CRC families. This opinion piece describes five strategies that could be incorporated into routine practice to improve identification and guideline-based screening in members of high-risk families. Routine incorporation of a simple family history screening tool and outreach to high-risk family members could substantially improve guideline-based screening in this population. Identification of CRCs and advanced adenomas in the endoscopy suite defines another group of high-risk families for similar outreach. Lynch syndrome families can be identified by testing CRCs and selected adenomas for microsatellite instability or loss of DNA repair protein expression. Finally, selective addition of aspirin to surveillance endoscopy can decrease the risk of new adenomas and CRCs. The rationale for these strategies as well as mechanisms for their implementation and evaluation in clinical practice is described.

Entities:  

Mesh:

Year:  2015        PMID: 25698379     DOI: 10.1007/s10620-015-3567-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  68 in total

Review 1.  Chemoprevention of colorectal cancer.

Authors:  P A Jänne; R J Mayer
Journal:  N Engl J Med       Date:  2000-06-29       Impact factor: 91.245

2.  ASGE guideline: colorectal cancer screening and surveillance.

Authors:  Raquel E Davila; Elizabeth Rajan; Todd H Baron; Douglas G Adler; James V Egan; Douglas O Faigel; Seng-Ian Gan; William K Hirota; Jonathan A Leighton; David Lichtenstein; Waqar A Qureshi; Bo Shen; Marc J Zuckerman; Trina VanGuilder; Robert D Fanelli
Journal:  Gastrointest Endosc       Date:  2006-04       Impact factor: 9.427

3.  Comparison of extended colectomy and limited resection in patients with Lynch syndrome.

Authors:  Nagendra Natarajan; Patrice Watson; Edibaldo Silva-Lopez; Henry T Lynch
Journal:  Dis Colon Rectum       Date:  2010-01       Impact factor: 4.585

Review 4.  Quality indicators for colonoscopy.

Authors:  Douglas K Rex; Philip S Schoenfeld; Jonathan Cohen; Irving M Pike; Douglas G Adler; M Brian Fennerty; John G Lieb; Walter G Park; Maged K Rizk; Mandeep S Sawhney; Nicholas J Shaheen; Sachin Wani; David S Weinberg
Journal:  Gastrointest Endosc       Date:  2014-12-02       Impact factor: 9.427

5.  Colorectal cancer statistics, 2014.

Authors:  Rebecca Siegel; Carol Desantis; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2014-03-17       Impact factor: 508.702

6.  The search for unaffected individuals with Lynch syndrome: do the ends justify the means?

Authors:  Heather Hampel; Albert de la Chapelle
Journal:  Cancer Prev Res (Phila)       Date:  2011-01

7.  Cancer risk assessment: examining the family physician's role.

Authors:  Carl V Tyler; Clint W Snyder
Journal:  J Am Board Fam Med       Date:  2006 Sep-Oct       Impact factor: 2.657

8.  Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.

Authors:  Bernard F Cole; Richard F Logan; Susan Halabi; Robert Benamouzig; Robert S Sandler; Matthew J Grainge; Stanislas Chaussade; John A Baron
Journal:  J Natl Cancer Inst       Date:  2009-02-10       Impact factor: 13.506

9.  Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial.

Authors:  John A Baron; Robert S Sandler; Robert S Bresalier; Angel Lanas; Dion G Morton; Robert Riddell; Erik R Iverson; David L Demets
Journal:  Lancet       Date:  2008-10-14       Impact factor: 79.321

10.  Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial.

Authors:  Monica M Bertagnolli; Craig J Eagle; Ann G Zauber; Mark Redston; Aurora Breazna; Kyungmann Kim; Jie Tang; Rebecca B Rosenstein; Asad Umar; Donya Bagheri; Neal T Collins; John Burn; Daniel C Chung; Thomas Dewar; T Raymond Foley; Neville Hoffman; Finlay Macrae; Ronald E Pruitt; John R Saltzman; Bruce Salzberg; Thomas Sylwestrowicz; Ernest T Hawk
Journal:  Cancer Prev Res (Phila)       Date:  2009-03-31
View more
  5 in total

Review 1.  Epigenetic Biomarkers in Colorectal Cancer.

Authors:  Mukesh Verma; Vineet Kumar
Journal:  Mol Diagn Ther       Date:  2017-04       Impact factor: 4.074

2.  Young-Onset Colorectal Cancer: Earlier Diagnoses or Increasing Disease Burden?

Authors:  Caitlin C Murphy; Jennifer L Lund; Robert S Sandler
Journal:  Gastroenterology       Date:  2017-04-28       Impact factor: 22.682

3.  CT Colonographic Screening of Patients With a Family History of Colorectal Cancer: Comparison With Adults at Average Risk and Implications for Guidelines.

Authors:  Perry J Pickhardt; Ifeanyi Mbah; B Dustin Pooler; Oliver T Chen; J Louis Hinshaw; Jennifer M Weiss; David H Kim
Journal:  AJR Am J Roentgenol       Date:  2017-01-26       Impact factor: 3.959

Review 4.  Increased Risk of Colorectal Cancer Tied to Advanced Colorectal Polyps: An Untapped Opportunity to Screen First-Degree Relatives and Decrease Cancer Burden.

Authors:  Jennifer M Kolb; Christine L Molmenti; Swati G Patel; David A Lieberman; Dennis J Ahnen
Journal:  Am J Gastroenterol       Date:  2020-07       Impact factor: 12.045

5.  Evaluation of an online family history tool for identifying hereditary and familial colorectal cancer.

Authors:  F G J Kallenberg; C M Aalfs; F O The; C A Wientjes; A C Depla; M W Mundt; P M M Bossuyt; E Dekker
Journal:  Fam Cancer       Date:  2018-07       Impact factor: 2.375

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.